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that the expectation-substitution method provides very
reliable inference (correct type I error rates under the null
hypothesis), good power under alternatives, and little bias
either in overall estimates or in confidence limits. It ap-
pears to be that only when the true ORs become extremely
large do some problems occur with the method, and,
frankly, from an epidemiological perspective, we should
be so lucky as to have very many association studies with
this problem!
PETER KRAFT AND DANIEL O. STRAM
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Reply to Peter Kraft and Daniel O. Stram
To the Editor: The main purpose of our original letter1 was
to show that the common practice of using the most prob-
able haplotype in association analysis can be dangerous.
We are glad that Kraft and Stram share this view and pro-
vide numerical support.2(in this issue) We agree with them that
the expectation-substitution method is generally prefer-
able to the use of the most probable haplotype. Because
it ignores the phenotype information and the case-control
sampling in the imputation, however, this method can
still yield biased and inefficient analysis of association. In
our original letter,1 we reported the power estimates of
62%, 49%, 42%, and 50% for detecting the effects of hap-
lotypes D, F, G, and H, respectively, in a simulation study
mimicking that of French et al.3 The corresponding power
estimates for the expectation-substitution method are
56%, 42%, 36%, and 42%. Thus, the expectation-substi-
tution method is considerably less powerful than the max-
imum-likelihood method.
The simulation results shown in table 2 of the letter by
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Kraft and Stram2 should be viewed with great caution.
First, the maximum-likelihood method implemented in
their simulation study pertains to the prospective likeli-
hood, which ignores the case-control sampling. Second,
the inclusion of haplotypes with very low frequencies can
cause numerical instabilities. Third, the setup of 32 hap-
lotypes with equal frequencies is highly unrealistic.
Imputation can be a good approximation of maximum
likelihood in many situations but can never be superior.
Given the availability of HAPSTAT and other user-friendly
software, there is no strong reason to not use proper max-
imum likelihood.
D. Y. LIN AND B. E. HUANG
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Impact of Array Comparative Genomic
Hybridization–Derived Information on Genetic
Counseling Demonstrated by Prenatal
Diagnosis of the TAR (Thrombocytopenia-
Absent-Radius) Syndrome–Associated
Microdeletion 1q21.1
To the Editor: The latest array-based genome-scanning
methods are beginning to revolutionize clinical genetics.1
Prominent recent examples derived from array technol-
ogies include the identification of new microdeletion syn-
dromes, such as the 17q21.3 microdeletion syndrome
(MIM 610443),2–4 and the elucidation of genomic loci har-
boring genes for CHARGE (MIM 214800)5 and Pitt-Hop-
kins syndrome (MIM 610954).6–8 Furthermore, array ap-
plications revealed a plethora of copy-number variations
(CNVs) in the human genome.9 Some of these CNVs likely
contribute to complex human disorders such as Crohn
disease (MIM 266600)10 and autism.11,12 An especially in-
teresting contribution of array comparative genomic hy-
bridization (array-CGH) has been helping to unravel the
cause of thrombocytopenia-absent-radius syndrome (TAR)
(MIM 274000), a rare syndrome characterized by bilateral
absence of the radii with presence of both thumbs and
thrombocytopenia,13 which was published in the February
2007 issue of the Journal.14 Klopocki et al.14 reported that
TAR syndrome has a complex pattern of inheritance as-
sociated with a common interstitial microdeletion of 200
kb on chromosome 1q21.1 and an additional, as-yet-un-
known modifier. This microdeletion was not present in
700 control samples and has not yet been described in the
Database of Genomic Variants.14
To exemplify how the new knowledge derived from ar-
ray-based analyses extends our ability to improve genetic
counseling, we describe here the prenatal case of a non-
consanguineous couple. The 42-year-old pregnant woman
(G2P0 at the time of counseling) and her 45-year-old hus-
band were referred to our genetic counseling service. Dur-
ing ultrasound examination at a gestational age of 16 wk,
bilateral phocomelia was found. No other abnormalities
were noted at that time, and the hands were not well
visualized. During the woman’s first pregnancy, phoco-
melia had also been noted at a gestational age of 14 wk,
and the pregnancy was terminated at the 22nd gestational
week. At this time, chromosome analysis from amnion
cells revealed a normal female karyotype (46,XX), and no
further analysis had been done. Both parents had an un-
remarkable phenotype.
If phocomelia is diagnosed during prenatal ultrasound
examination, the most important differential diagnoses
include TAR (MIM 274000), Holt-Oram (MIM 142900),
and Roberts syndrome (MIM 268300). In the latter two
conditions, the thumb is usually absent or severely hy-
poplastic. However, hands may not always be well visu-
alized during an ultrasound, and occasionally patients
with Roberts syndrome may exhibit normal thumbs.15
Thus, on the basis of ultrasound examination alone, a
definite diagnosis is impossible. In both TAR and Holt-
Oram syndromes, conventional cytogenetic analysis usu-
ally yields normal karyotypes, whereas ∼80% of cases with
Roberts syndrome exhibit a chromosomal phenomenon
known as “premature centromere separation.”16 There-
fore, conventional chromosome banding analysis is often
inconclusive. As a consequence, cordocentesis is often
considered to evaluate fetal platelet count,17–20 because, in
TAR, platelet counts are often !50 platelets/nl (normal
range 150–400 platelets/nl).21 Although such a fetal plate-
let count is mandatory to establish the diagnosis of TAR
syndrome and to differentiate it from other syndromes
with malformations of the upper limbs, cordocentesis
was reported to have a 1%–2% risk of fetal loss.22 In ad-
dition, thrombocytopenia may not appear before the third
trimester of pregnancy or even until the first months of
life,23 making an early diagnosis based on platelet count
difficult.
To provide accurate genetic counseling, it is essential to
make a correct diagnosis. In this case, we could utilize the
very recent information about inheritance of TAR syn-
